Whole-genome CRISPR screening identifies genetic manipulations to reduce immune rejection of stem cell-derived islets

Human embryonic stem cells (hESCs) provide opportunities for cell replacement therapy of insulin-dependent diabetes. Therapeutic quantities of human stem cell-derived islets (SC-islets) can be produced by directed differentiation. However, preventing allo-rejection and recurring autoimmunity, withou...

Descripción completa

Detalles Bibliográficos
Autores principales: Sintov, Elad, Nikolskiy, Igor, Barrera, Victor, Hyoje-Ryu Kenty, Jennifer, Atkin, Alexander S., Gerace, Dario, Ho Sui, Shannan J., Boulanger, Kyle, Melton, Douglas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481918/
https://www.ncbi.nlm.nih.gov/pubmed/36055241
http://dx.doi.org/10.1016/j.stemcr.2022.08.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481918/
https://www.ncbi.nlm.nih.gov/pubmed/36055241
http://dx.doi.org/10.1016/j.stemcr.2022.08.002

Ejemplares similares